89 related articles for article (PubMed ID: 32787474)
1. Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence.
Zou Y; Chen X; Zhang X; Shen Z; Cai J; Tan Y; Weng J; Rong Y; Lin X
Int J Hyperthermia; 2020; 37(1):944-954. PubMed ID: 32787474
[TBL] [Abstract][Full Text] [Related]
2. External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy.
Kozman MA; Fisher OM; Liauw W; Morris DL; Cashin PH
J Surg Oncol; 2023 Dec; 128(7):1150-1159. PubMed ID: 37602499
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Metastases in Colorectal Cancer: Biology and Barriers.
Xue L; Hyman NH; Turaga KK; Eng OS
J Gastrointest Surg; 2020 Mar; 24(3):720-727. PubMed ID: 31745890
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes between surgical treatment of colorectal cancer metastatic to the liver and the peritoneum: Review of the literature.
Cos H; Shen P
J Surg Oncol; 2024 Jan; 129(1):85-90. PubMed ID: 37990864
[TBL] [Abstract][Full Text] [Related]
5. Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature.
Erali RA; Forsythe SD; Gironda DJ; Schaaf CR; Wajih N; Soker S; Votanopoulos KI
J Gastrointest Cancer; 2023 Sep; 54(3):712-719. PubMed ID: 36447085
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after curatively intended treatment of limited peritoneal metastases and thermal ablation for liver metastases from colorectal cancer.
Balachandran R; Sørensen MM; Funder JA; Knudsen AR; Iversen LH
Pleura Peritoneum; 2023 Dec; 8(4):167-174. PubMed ID: 38144219
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
Zou M; Li PH; Yang ZQ; Gao F
Ann Surg Oncol; 2023 Oct; 30(11):6775-6776. PubMed ID: 37454016
[No Abstract] [Full Text] [Related]
8. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profile-Guided Personalized Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Carcinomatosis.
Markovich VA; Tuzikov SA; Rodionov EO; Popova NO; Tsyganov MM; Miller SV; Podolko DV; Tsydenova IA; Ibragimova MK; Litviakov NV
World J Oncol; 2024 Apr; 15(2):298-308. PubMed ID: 38545480
[TBL] [Abstract][Full Text] [Related]
10. Authors' Response to the Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
Khaled C; El Asmar A; Liberale G
Ann Surg Oncol; 2023 Nov; 30(12):7643-7644. PubMed ID: 37620538
[No Abstract] [Full Text] [Related]
11. Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
Gudmundsdottir H; Fogliati A; Grotz TE; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Halfdanarson TR; Cleary SP; Starlinger P
Ann Surg Oncol; 2024 Apr; ():. PubMed ID: 38689169
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis.
Cheng B; Ye S; Bai P
World J Surg Oncol; 2021 May; 19(1):160. PubMed ID: 34051809
[TBL] [Abstract][Full Text] [Related]
13. The Role of Total Parenteral Nutrition in Patients with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.
Ong XS; Sultana R; Tan JW; Tan QX; Wong JSM; Chia CS; Ong CJ
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439309
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.
Monelli F; Besutti G; Djuric O; Bonvicini L; Farì R; Bonfatti S; Ligabue G; Bassi MC; Damato A; Bonelli C; Pinto C; Pattacini P; Giorgi Rossi P
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067076
[TBL] [Abstract][Full Text] [Related]
15. Complete Blood Count Alterations Prior to the Diagnosis of Colorectal Cancer May Help in the Detection of Synchronous Liver Metastases.
Sala RJ; Ery J; Cuesta-Peredo D; Muedra V; Rodilla V
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892677
[No Abstract] [Full Text] [Related]
16. Application of artificial intelligence in the diagnosis, treatment, and recurrence prediction of peritoneal carcinomatosis.
Wei GX; Zhou YW; Li ZP; Qiu M
Heliyon; 2024 Apr; 10(7):e29249. PubMed ID: 38601686
[TBL] [Abstract][Full Text] [Related]
17. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways: Targeting the Microenvironment of Liver Metastases.
Milette S; Sicklick JK; Lowy AM; Brodt P
Clin Cancer Res; 2017 Nov; 23(21):6390-6399. PubMed ID: 28615370
[TBL] [Abstract][Full Text] [Related]
19. Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.
van Oosten M; Crane LM; Bart J; van Leeuwen FW; van Dam GM
Transl Oncol; 2011 Apr; 4(2):71-82. PubMed ID: 21461170
[TBL] [Abstract][Full Text] [Related]
20. A call for standardized reporting of early-onset colorectal peritoneal metastases.
Austin-Datta RJ; La Vecchia C; George TJ; Mohamed F; Boffetta P; Dineen SP; Huang DQ; Vu TT; Nguyen TC; Permuth JB; Luu HN
Eur J Cancer Prev; 2023 Nov; 32(6):548-556. PubMed ID: 37310397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
